These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15139565)

  • 1. Pressure and inspiratory flow characteristics of dry powder inhalers.
    Cegla UH
    Respir Med; 2004 Apr; 98 Suppl A():S22-8. PubMed ID: 15139565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novolizer: how does it fit into inhalation therapy?
    Magnussen H
    Curr Med Res Opin; 2005; 21 Suppl 4():S39-46; discussion S47. PubMed ID: 16138944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peak inspiratory flow rates generated through the Novolizer and the Turbuhaler dry powder inhaler devices by children with stable asthma.
    von Berg A; Kremer HJ; Ellers-Lenz B; Conrad F; Erb K; Maus J; Hermann R
    J Aerosol Med; 2007; 20(1):50-8. PubMed ID: 17388753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhalation characteristics of asthma patients, COPD patients and healthy volunteers with the Spiromax® and Turbuhaler® devices: a randomised, cross-over study.
    Azouz W; Chetcuti P; Hosker H; Saralaya D; Chrystyn H
    BMC Pulm Med; 2015 May; 15():47. PubMed ID: 25927483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhalation profiles in asthmatics and COPD patients: reproducibility and effect of instruction.
    Broeders ME; Molema J; Hop WC; Folgering HT
    J Aerosol Med; 2003; 16(2):131-41. PubMed ID: 12823907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful use of DPI systems in asthmatic patients--key parameters.
    Richter K
    Respir Med; 2004 Oct; 98 Suppl B():S22-7. PubMed ID: 15481285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ideal inhaler: design and characteristics to improve outcomes.
    O'Connor BJ
    Respir Med; 2004 Apr; 98 Suppl A():S10-6. PubMed ID: 15139563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Novolizer: overcoming inherent problems of dry powder inhalers.
    Kohler D
    Respir Med; 2004 Apr; 98 Suppl A():S17-21. PubMed ID: 15139564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novolizer: a multidose dry powder inhaler.
    Fenton C; Keating GM; Plosker GL
    Drugs; 2003; 63(22):2437-45; discussion 2447-8. PubMed ID: 14609355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Difference in resistance to humidity between commonly used dry powder inhalers: an in vitro study.
    Janson C; Lööf T; Telg G; Stratelis G; Nilsson F
    NPJ Prim Care Respir Med; 2016 Nov; 26():16053. PubMed ID: 27853177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of Turbuhaler((R)) in Patients with Acute Airway Obstruction and COPD, and in Children with Asthma : Understanding the Clinical Importance of Adequate Peak Inspiratory Flow, High Lung Deposition, and Low In Vivo Dose Variability.
    Selroos O; Borgström L; Ingelf J
    Treat Respir Med; 2006; 5(5):305-15. PubMed ID: 16928144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The efficacy of Turbuhaler dry powder inhaler in Japanese asthma--measurement of peak inspiratory flow when using Turbuhaler].
    Kaneko N; Narushima M; Tanaka K; Suzuki H
    Arerugi; 1996 Jul; 45(7):649-54. PubMed ID: 8831169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Novolizer: a multidose dry powder inhaler.
    Siddiqui MA; Plosker GL
    Treat Respir Med; 2005; 4(1):63-9. PubMed ID: 15725051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomised open-label cross-over study of inhaler errors, preference and time to achieve correct inhaler use in patients with COPD or asthma: comparison of ELLIPTA with other inhaler devices.
    van der Palen J; Thomas M; Chrystyn H; Sharma RK; van der Valk PD; Goosens M; Wilkinson T; Stonham C; Chauhan AJ; Imber V; Zhu CQ; Svedsater H; Barnes NC
    NPJ Prim Care Respir Med; 2016 Nov; 26():16079. PubMed ID: 27883002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inspiratory flow rates at different levels of resistance in elderly COPD patients.
    Janssens W; VandenBrande P; Hardeman E; De Langhe E; Philps T; Troosters T; Decramer M
    Eur Respir J; 2008 Jan; 31(1):78-83. PubMed ID: 17898020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung characteristics in elderly males and females patients with COPD: differences and optimal use of dry powder inhalers (DPIs).
    Terzano C; Oriolo F
    Eur Rev Med Pharmacol Sci; 2017 Jun; 21(11):2708-2716. PubMed ID: 28678314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ventolin Diskus and Inspyril Turbuhaler: an in vitro comparison.
    Broeders ME; Molema J; Burnell PK; Folgering HT
    J Aerosol Med; 2005; 18(1):74-82. PubMed ID: 15741776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Peak inspiratory flow generated through different analogue dry powder inhalers in Shenzhen healthy preschool children].
    Zhang QL; Zheng JP; Pan WH; He H; Chen GL; An JY; Yuan LF; Luo DF
    Zhonghua Er Ke Za Zhi; 2008 Feb; 46(2):98-103. PubMed ID: 19099680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation of the peak inspiratory flow generated by asthmatic children through the Novolizer.
    Vogelberg C; Kremer HJ; Ellers-Lenz B; Engel M; Maus J; Conrad F; Hermann R
    Respir Med; 2004 Oct; 98(10):924-31. PubMed ID: 15481267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of patient preference and ease of teaching inhaler technique for Pulmicort Turbuhaler versus pressurized metered-dose inhalers.
    Welch MJ; Nelson HS; Shapiro G; Bensch GW; Sokol WN; Smith JA; Parasuraman BM
    J Aerosol Med; 2004; 17(2):129-39. PubMed ID: 15294063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.